Παρακολούθηση
Arvind Bansal
Arvind Bansal
Professor of Pharmaceutics, NIPER
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα niper.ac.in - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Polymorphs, salts, and cocrystals: what’s in a name?
S Aitipamula, R Banerjee, AK Bansal, K Biradha, ML Cheney, ...
Crystal growth & design 12 (5), 2147-2152, 2012
11622012
A means to address regional variability in intestinal drug absorption
G Chawla, A Bansal
Pharm tech 27 (2), 50-68, 2003
5142003
Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids
B Shah, VK Kakumanu, AK Bansal
Journal of pharmaceutical sciences 95 (8), 1641-1665, 2006
4662006
Amorphous drug delivery systems: molecular aspects, design, and performance
AM Kaushal, P Gupta, AK Bansal
Critical Reviews™ in Therapeutic Drug Carrier Systems 21 (3), 2004
3662004
Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model
B Wahlang, YB Pawar, AK Bansal
European Journal of Pharmaceutics and Biopharmaceutics 77 (2), 275-282, 2011
3012011
Compression physics in the formulation development of tablets
S Patel, AM Kaushal, AK Bansal
Critical Reviews™ in therapeutic drug carrier systems 23 (1), 2006
2982006
Coprocessed excipients for solid dosage forms
SK Nachaegari, AK Bansal
Pharmaceutical technology (2003) 28 (1), 52-64, 2004
2782004
Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective
P Gupta, VK Kakumanu, AK Bansal
Pharmaceutical research 21, 1762-1769, 2004
2692004
Trends in pharmaceutical taste masking technologies: a patent review
Z Ayenew, V Puri, L Kumar, AK Bansal
Recent patents on drug delivery & formulation 3 (1), 26-39, 2009
2292009
Characterization of solid-state forms of celecoxib
G Chawla, P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal
European Journal of Pharmaceutical Sciences 20 (3), 305-317, 2003
2082003
Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility
P Gupta, G Chawla, AK Bansal
Molecular pharmaceutics 1 (6), 406-413, 2004
1952004
Effect of particle size and compression force on compaction behavior and derived mathematical parameters of compressibility
S Patel, AM Kaushal, AK Bansal
Pharmaceutical research 24, 111-124, 2007
1842007
Drug-excipient behavior in polymeric amorphous solid dispersions
SB Teja, SP Patil, G Shete, S Patel, AK Bansal
International Journal of Pharmaceutical Excipients 4 (3), 2016
1762016
Role of molecular interaction in stability of celecoxib− PVP amorphous systems
P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal
Molecular pharmaceutics 2 (5), 384-391, 2005
1652005
Excipients used in lyophilization of small molecules
A Baheti, L Kumar, AK Bansal
Journal of Excipients and Food Chemicals 1 (1), 41-54, 2010
1642010
SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection
RP Joshi, G Negi, A Kumar, YB Pawar, B Munjal, AK Bansal, SS Sharma
Nanomedicine: Nanotechnology, Biology and Medicine 9 (6), 776-785, 2013
1602013
Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples
G Shete, V Puri, L Kumar, AK Bansal
AAPS PharmSciTech 11 (2), 598-609, 2010
1522010
Self-emulsifying drug delivery systems: a strategy to improve oral bioavailability
K Sarpal, YB Pawar, AK Bansal
Current Research & Information on Pharmaceuticals Sciences (CRIPS) 11 (3), 42-49, 2010
1312010
Quantification of olanzapine polymorphs using powder X-ray diffraction technique
M Tiwari, G Chawla, AK Bansal
Journal of pharmaceutical and biomedical analysis 43 (3), 865-872, 2007
1262007
Challenges in translational development of pharmaceutical cocrystals
DP Kale, SS Zode, AK Bansal
Journal of pharmaceutical sciences 106 (2), 457-470, 2017
1232017
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20